SCHEMBL3933183

SCHEMBL3933183

Cc1ccc([N+](=O)[O-])cc1C(=O)Nc1cccnc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.71
CYP11B2 P19099 2/20 0.65
CYP11B1 P15538 1/20 0.65
KMT2A Q03164 3/20 0.60
MEN1 O00255 1/20 0.60
BRAF P15056 5/20 0.58
MAPT P10636 3/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
ALDH1A1 P00352 2/20 0.58
POLB P06746 1/20 0.56
RECQL P46063 1/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
CSF1R P07333 1/20 0.54
KIT P10721 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26758011 0.88 SMN1; SMN2 (0.74) SMN1; SMN2CYP11B2CYP11B1KMT2AMEN1
SCHEMBL2950162 0.86 SMN1; SMN2 (0.53) SMN1; SMN2KMT2AMEN1MAPTCYP1A2
SCHEMBL3937705 0.85 SMN1; SMN2 (0.82) SMN1; SMN2CYP11B2CYP11B1KMT2AMEN1
SCHEMBL3936626 0.85 SMN1; SMN2 (0.71) SMN1; SMN2CYP11B2CYP11B1KMT2AMEN1
SCHEMBL3934052 0.85 GAA (0.69) SMN1; SMN2CYP11B2CYP11B1KMT2AMEN1
SCHEMBL3935767 0.80 MAPT (0.57) SMN1; SMN2KMT2AMEN1BRAFMAPT
SCHEMBL7128348 0.80 SMN1; SMN2 (0.72) SMN1; SMN2CYP11B2CYP11B1KMT2AMEN1
SCHEMBL3934041 0.80 BRAF (0.63) CYP11B2CYP11B1KMT2AMEN1BRAF
SCHEMBL13161982 0.80 BRAF (0.74) CYP11B2CYP11B1BRAFMAPTPOLB
SCHEMBL7371634 0.79 CYP11B1 (1.00) SMN1; SMN2CYP11B2CYP11B1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed
CN-101128454-A Pyridine carboxamide derivatives for use as anticancer agents ASTRAZENECA AB (SE) 2008-02-20 CN disclosed